An overview on the anticancer activity of Ru(II)/acylthiourea complexes

A Phase I and Pharmacological Study with Imidazolium-<b> <i>trans-</i> </b>DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent

Jeany M. Rademaker-Lakhai, H.J.G.D. van den Bongard, Dick Pluim et al. · Clinical Cancer Research · 2004 · 820 citations · Full text

NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application

Robert Trondl, Petra Heffeter, Christian R. Kowol et al. · Chemical Science · 2014 · 652 citations · Full text

Chemoprevention Strategy, Pharmacotherapy, Tumor Biology +16

The development of RAPTA compounds for the treatment of tumors

Benjamin S. Murray, Maria V. Babak, Christian G. Hartinger et al. · Coordination Chemistry Reviews · 2015 · 449 citations · Full text

Tumor Biology, Medicinal Chemistry, Medicine +7

Metal complex interactions with DNA

Benjamin J. Pages, Dale L. Ang, Elisé P. Wright et al. · Dalton Transactions · 2014 · 431 citations

Metal Chain Compound, Inorganic Chemistry, Engineering +14

Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy

Suzanne Leijen, Sjaak A. Burgers, Paul Baas et al. · Investigational New Drugs · 2014 · 365 citations · Full text

Oncology, Phase I/ii Study, Medicine +10